Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q1 2018 (← Previous) (Next →)

Filing Date: May 15, 2018

Total Value ($000): $568,612 (100.0% shares, 0.0% debt)

Holdings (31)

— LOXO ONCOLOGY INC 7.3%

Value ($000) $41,533 Shares 360,000 Est. Cost $28.44 Unrealized —

— FOUNDATION MEDICINE INC 7.2%

Value ($000) $40,950 Shares 520,000 Est. Cost $22.74 Unrealized —

— SAGE THERAPEUTICS INC 7.1%

Value ($000) $40,268 Shares 250,000 Est. Cost $52.53 Unrealized —

— BLUEPRINT MEDICINES CORP 5.6%

Value ($000) $31,912 Shares 348,000 Est. Cost $37.87 Unrealized —

— SPARK THERAPEUTICS INC 5.4%

Value ($000) $30,831 Shares 463,000 Est. Cost $58.74 Unrealized —

AGIO AGIOS PHARMACEUTICALS INC 5.2%

Value ($000) $29,831 Shares 364,776 Est. Cost $57.83 Unrealized +33.7%

ALNY ALNYLAM PHARMACEUTICALS INC 5.2%

Value ($000) $29,775 Shares 250,000 Est. Cost $84.46 Unrealized +52.6%

— GLOBAL BLOOD THERAPEUTICS IN 5.1%

Value ($000) $28,980 Shares 600,000 Est. Cost $32.45 Unrealized —

— MYOKARDIA INC 4.8%

Value ($000) $27,328 Shares 560,000 Est. Cost $22.11 Unrealized —

SGMO SANGAMO THERAPEUTICS INC 4.7%

Value ($000) $26,600 Shares 1,400,000 Est. Cost $4.96 Unrealized +331.4%

FATE FATE THERAPEUTICS INC 4.5%

Value ($000) $25,376 Shares 2,600,000 Est. Cost $4.33 Unrealized +121.3%

— BLUEBIRD BIO INC 4.4%

Value ($000) $24,759 Shares 145,000 Est. Cost $115.06 Unrealized —

CDXS CODEXIS INC 3.9%

Value ($000) $22,275 Shares 2,025,000 Est. Cost $5.90 Unrealized +62.2%

VYGR VOYAGER THERAPEUTICS INC 3.8%

Value ($000) $21,327 Shares 1,135,000 Est. Cost $14.86 Unrealized —

— GENMARK DIAGNOSTICS INC 3.7%

Value ($000) $20,944 Shares 3,850,000 Est. Cost $6.84 Unrealized —

ILMN ILLUMINA INC 3.0%

Value ($000) $16,904 Shares 71,500 Est. Cost $196.93 Unrealized +16.4%

EVH EVOLENT HEALTH INC 2.8%

Value ($000) $15,818 Shares 1,110,000 Est. Cost $17.59 Unrealized -18.6%

— JOUNCE THERAPEUTICS INC 2.5%

Value ($000) $14,192 Shares 635,000 Est. Cost $18.19 Unrealized —

— AUDENTES THERAPEUTICS INC 2.4%

Value ($000) $13,523 Shares 450,000 Est. Cost $19.14 Unrealized —

ONC BEIGENE LTD 2.1%

Value ($000) $11,760 Shares 70,000 Est. Cost $149.93 Unrealized —

IBB ISHARES TR 1.8%

Value ($000) $10,140 Shares 95,000 Est. Cost $106.74 Unrealized —

— CLOVIS ONCOLOGY INC 1.6%

Value ($000) $9,372 Shares 177,500 Est. Cost $78.32 Unrealized —

CRSP CRISPR THERAPEUTICS AG 1.1%

Value ($000) $6,171 Shares 135,000 Est. Cost $41.27 Unrealized 0.0%

CTMX CYTOMX THERAPEUTICS INC 1.0%

Value ($000) $5,903 Shares 207,500 Est. Cost $17.02 Unrealized +67.7%

EDIT EDITAS MEDICINE INC 0.8%

Value ($000) $4,420 Shares 133,333 Est. Cost $20.61 Unrealized +72.9%

NEOG NEOGEN CORP 0.8%

Value ($000) $4,354 Shares 65,000 Est. Cost $30.13 Unrealized 0.0%

OSUR ORASURE TECHNOLOGIES INC 0.7%

Value ($000) $4,054 Shares 240,000 Est. Cost $18.96 Unrealized 0.0%

— CELGENE CORP 0.6%

Value ($000) $3,568 Shares 40,000 Est. Cost — Unrealized —

ZLAB ZAI LAB LTD 0.5%

Value ($000) $2,882 Shares 135,000 Est. Cost $21.35 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 0.3%

Value ($000) $1,740 Shares 300,000 Est. Cost $5.80 Unrealized —

— HOMOLOGY MEDICINES INC 0.2%

Value ($000) $1,122 Shares 60,000 Est. Cost $18.70 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	LOXO ONCOLOGY INC	360,000	$41,533	7.3%	$28.44	—	COM	548862101
—	FOUNDATION MEDICINE INC	520,000	$40,950	7.2%	$22.74	—	COM	350465100
—	SAGE THERAPEUTICS INC	250,000	$40,268	7.1%	$52.53	—	COM	78667J108
—	BLUEPRINT MEDICINES CORP	348,000	$31,912	5.6%	$37.87	—	COM	09627Y109
—	SPARK THERAPEUTICS INC	463,000	$30,831	5.4%	$58.74	—	COM	84652J103
AGIO	AGIOS PHARMACEUTICALS INC	364,776	$29,831	5.2%	$57.83	+33.7%	COM	00847X104
ALNY	ALNYLAM PHARMACEUTICALS INC	250,000	$29,775	5.2%	$84.46	+52.6%	COM	02043Q107
—	GLOBAL BLOOD THERAPEUTICS IN	600,000	$28,980	5.1%	$32.45	—	COM	37890U108
—	MYOKARDIA INC	560,000	$27,328	4.8%	$22.11	—	COM	62857M105
SGMO	SANGAMO THERAPEUTICS INC	1,400,000	$26,600	4.7%	$4.96	+331.4%	COM	800677106
FATE	FATE THERAPEUTICS INC	2,600,000	$25,376	4.5%	$4.33	+121.3%	COM	31189P102
—	BLUEBIRD BIO INC	145,000	$24,759	4.4%	$115.06	—	COM	09609G100
CDXS	CODEXIS INC	2,025,000	$22,275	3.9%	$5.90	+62.2%	COM	192005106
VYGR	VOYAGER THERAPEUTICS INC	1,135,000	$21,327	3.8%	$14.86	—	COM	92915B106
—	GENMARK DIAGNOSTICS INC	3,850,000	$20,944	3.7%	$6.84	—	COM	372309104
ILMN	ILLUMINA INC	71,500	$16,904	3.0%	$196.93	+16.4%	COM	452327109
EVH	EVOLENT HEALTH INC	1,110,000	$15,818	2.8%	$17.59	-18.6%	CL A	30050B101
—	JOUNCE THERAPEUTICS INC	635,000	$14,192	2.5%	$18.19	—	COM	481116101
—	AUDENTES THERAPEUTICS INC	450,000	$13,523	2.4%	$19.14	—	COM	05070R104
ONC	BEIGENE LTD	70,000	$11,760	2.1%	$149.93	—	SPONSORED ADR	07725L102
IBB	ISHARES TR	95,000	$10,140	1.8%	$106.74	—	NASDAQ BIOTECH	464287556
—	CLOVIS ONCOLOGY INC	177,500	$9,372	1.6%	$78.32	—	COM	189464100
CRSP	CRISPR THERAPEUTICS AG	135,000	$6,171	1.1%	$41.27	0.0%	NAMEN AKT	H17182108
CTMX	CYTOMX THERAPEUTICS INC	207,500	$5,903	1.0%	$17.02	+67.7%	COM	23284F105
EDIT	EDITAS MEDICINE INC	133,333	$4,420	0.8%	$20.61	+72.9%	COM	28106W103
NEOG	NEOGEN CORP	65,000	$4,354	0.8%	$30.13	0.0%	COM	640491106
OSUR	ORASURE TECHNOLOGIES INC	240,000	$4,054	0.7%	$18.96	0.0%	COM	68554V108
—	CELGENE CORP	40,000	$3,568	0.6%	—	—	Call	151020104
ZLAB	ZAI LAB LTD	135,000	$2,882	0.5%	$21.35	—	ADR	98887Q104
—	ADVERUM BIOTECHNOLOGIES INC	300,000	$1,740	0.3%	$5.80	—	COM	00773U108
—	HOMOLOGY MEDICINES INC	60,000	$1,122	0.2%	$18.70	—	COM	438083107